Eric  M. Meslin
Eric M. Meslin
Professor of Bioethics, Indiana University
Verified email at
TitleCited byYear
Medical ethics education: where are we? Where should we be going? A review
RE Eckles, EM Meslin, M Gaffney, PR Helft
Academic Medicine 80 (12), 1143-1152, 2005
Hereditary hemochromatosis: gene discovery and its implications for population-based screening
W Burke, E Thomson, MJ Khoury, SM McDonnell, N Press, PC Adams, ...
Jama 280 (2), 172-178, 1998
Research ethics recommendations for whole-genome research: consensus statement
T Caulfield, AL McGuire, M Cho, JA Buchanan, MM Burgess, U Danilczyk, ...
PLoS biology 6 (3), 2008
Ethical issues in the design and conduct of clinical trials in developing countries
HT Shapiro, EM Meslin
New England Journal of Medicine 345 (2), 139-142, 2001
Deflating the genomic bubble
JP Evans, EM Meslin, TM Marteau, T Caulfield
Science 331 (6019), 861-862, 2011
Measuring the ethical sensitivity of medical students: a study at the University of Toronto.
PC Hebert, EM Meslin, EV Dunn
Journal of medical ethics 18 (3), 142-147, 1992
Evaluating ethical sensitivity in medical students: using vignettes as an instrument.
P Hébert, EM Meslin, EV Dunn, N Byrne, SR Reid
Journal of medical ethics 16 (3), 141-145, 1990
Bioethics for clinicians: 13. Resource allocation
MF McKneally, BM Dickens, EM Meslin, PA Singer
Cmaj 157 (2), 163-167, 1997
Bioethics for clinicians: 3. Capacity.
E Etchells, G Sharpe, C Elliott, PA Singer
CMAJ: Canadian Medical Association journal 155 (6), 657, 1996
Belmont revisited: Ethical principles for research with human subjects
JF Childress
Georgetown University Press, 2005
Bioethics for clinicians: 10. Research ethics
C Weijer, B Dickens, EM Meslin
Cmaj 156 (8), 1153-1157, 1997
Extending the reach of public health genomics: what should be the agenda for public health in an era of genome-based and “personalized” medicine?
W Burke, H Burton, AE Hall, M Karmali, MJ Khoury, B Knoppers, ...
Genetics in Medicine 12 (12), 785-791, 2010
Helsinki discords: FDA, ethics, and international drug trials
J Kimmelman, C Weijer, EM Meslin
Agreement on disease-specific criteria for do-not-resuscitate orders in acute stroke
AV Alexandrov, PM Pullicino, EM Meslin, JW Norris
Stroke 27 (2), 232-237, 1996
The ethical, legal, and social implications research program at the National Human Genome Research Institute
EJ Thomson, JT Boyer, EM Meslin
Kennedy Institute of Ethics Journal 7 (3), 291-298, 1997
A review of the key issues associated with the commercialization of biobanks
T Caulfield, S Burningham, Y Joly, Z Master, M Shabani, P Borry, ...
Journal of Law and the Biosciences 1 (1), 94-110, 2014
Bioethics for clinicians: 16. Dealing with demands for inappropriate treatment
C Weijer, PA Singer, BM Dickens, S Workman
Cmaj 159 (7), 817-821, 1998
Is there a role for preference assessments in research on quality of life in oncology?
JE Till, HJ Sutherland, EM Meslin
Quality of Life Research 1 (1), 31-40, 1992
Ethical issues in the collection, storage, and research use of human biological materials
EM Meslin, KA Quaid
Journal of Laboratory and Clinical Medicine 144 (5), 229-234, 2004
Mapping the translational science policy ‘valley of death’
EM Meslin, A Blasimme, A Cambon-Thomsen
Clinical and translational medicine 2 (1), 14, 2013
The system can't perform the operation now. Try again later.
Articles 1–20